SIShuhei Ideguchi

Shuhei Ideguchi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shuhei Ideguchi has a total of 61 co-authors. Here are the top co-authors by number of shared publications:

  • Kazuko Yamamoto

    First Department of Internal Medicine, Division of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus Graduate School of Medicine , Ginowan, Okinawa

    6 shared publications
  • Hiroshi Mukae

    Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan

    3 shared publications
  • Jiro Fujita

    Department of Respiratory Medicine, Ohama Dai-ichi Hospital, Naha, 900-0005, Japan

    2 shared publications
  • Masashi Nakamatsu

    Department of Infection Control, University of the Ryukyus Hospital, Ginowan, 901-2222, Japan

    2 shared publications
  • Shusaku Haranaga

    University of the Ryukyus Comprehensive Health Professions Education Center, University Hospital, Ginowan, 901-2222, Japan

    2 shared publications
  • Takahiro Takazono

    Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

    2 shared publications

Latest Publications

  • Open Access

    COVID-19 cluster outbreaks and infection control measures in nursing homes in Okinawa: protocol for a retrospective observational study

    by Shuhei Ideguchi, Yoshihiro Takayama, Nanae Ikemiyagi, Fuki Ujimiya, Kazutaka Yamaniha, Miki Imura, Kosuke Tanabe, Kazuko Yamamoto

    Introduction: Following the reclassification of COVID-19 as a category V infectious disease in Japan in May 2023, systematic public health monitoring of case numbers and cluster outbreaks was discontinued. Consequently, infection control measures, responses to cluster outbreaks and vaccination coverage in long-term care facilities were largely left to the discretion of individual facilities, and the understanding of the current situation in these settings remains insufficient. This observational study aims to retrospectively investigate COVID-19 cluster outbreaks and the resulting burdens experienced by facilities after reclassification, focusing on special nursing homes (Tokubetsu Yogo Rojin Home) for older adults, a population at particularly high risk for COVID-19-associated hospitalisation and mortality. By comprehensively evaluating facility and resident characteristics, vaccination coverage and infection prevention and control measures, this study seeks to generate evidence to inform future infection control strategies in long-term care facilities. Methods and analysis: This retrospective observational study targets special nursing homes in Okinawa Prefecture and residents living in these facilities. Data for a target sample of nine nursing homes with approximately 900 residents will be collected from existing facility and medical records using the Research Electronic Data Capture system. The study was initiated in June 2025 and completion is anticipated by March 2027. The primary outcomes are the occurrence of COVID-19 cluster outbreaks in nursing homes between May 2023 and August 2025 and the facility-level burden experienced during outbreaks, including operational and economic impacts. A cluster outbreak is defined as the occurrence of ≥2 cases of the same infectious disease within a 10-day period. Key variables of interest include baseline characteristics of facilities and residents, vaccination coverage among staff and residents and infection prevention and control measures. Additionally, the study explores potential factors associated with residents’ clinical outcomes and facility burden using logistic and linear regression models, respectively, with facility-level random intercepts if deemed appropriate. Prespecified supplementary analyses include one-way analysis of variance and χ 2 tests. Ethics and dissemination: The study protocol was approved by the Institutional Review Board of the University of the Ryukyus in June 2025 (approval number: 25-2486-00-00-00). The findings will be disseminated at academic conferences and in peer-reviewed medical journals.

  • Bacterial pneumonia co-infection in adult inpatients with coronavirus disease 2019 during the Omicron variants epidemic in Okinawa, Japan: risk factors and clinical outcomes

    by Wakaki Kami, Shuhei Ideguchi, Kazuya Miyagi, Daisuke Tasato, Futoshi Higa, Hideta Nakamura, Takeshi Kinjo, Masashi Nakamatsu, Shusaku Haranaga, Akihiro Tokushige, et al.


  • Open Access

    Unseasonal respiratory syncytial virus epidemics during the COVID-19 pandemic: Relationship between climatic factors and epidemic strain switching

    by Akira Shinzato, Kenji Hibiya, Naoya Nishiyama, Nanae Ikemiyagi, Wakako Arakaki, Wakaki Kami, Daijiro Nabeya, Shuhei Ideguchi, Hideta Nakamura, Makoto Furugen, et al.


  • Letter from Japan

    by Shuhei Ideguchi, Kazuko Yamamoto


  • Open Access

    Clinical features relating to pneumococcal colony phase variation in hospitalized adults with pneumonia

    by Shuhei Ideguchi, Kazuko Yamamoto, Takahiro Takazono, Yuichi Fukuda, Takahiro Tashiro, Sayaka Shizukuishi, Bin Chang, Michinaga Ogawa, Koichi Izumikawa, Katsunori Yanagihara, et al.

    Background. Streptococcus pneumoniae is a major causative bacteria of pneumonia and invasive pneumococcal disease (IPD); however, the mechanisms underlying its severity and invasion remain to be defined. Pneumococcal colonies exhibit opaque and transparent opacity phase variations, which have been associated with invasive infections and nasal colonization, respectively, in animal studies. This study evaluated the relationship between the opacity of pneumococcal colonies and the clinical presentation of pneumococcal pneumonia. Methods. This retrospective study included adult patients hospitalized with pneumococcal pneumonia between 2012 and 2019 at four tertiary medical institutions. Pneumococcal strains from lower respiratory tract specimens were determined for their serotypes and microscopic colony opacity, and the association between the opacity phase and the severity of pneumonia was evaluated. Serotypes 3 and 37 with mucoid colony phenotypes were excluded from the study because their colony morphologies were clearly different. Results. A total of 92 patients were included. Most patients were older adults (median age: 72 years) and males (67 %), and 59 % had community-acquired pneumonia. Of the 92 patients, 41 (45 %), 12 (13 %), and 39 (42 %) patients had opaque, transparent, and mixed variants in their pneumococcal colony, respectively. The opaque and non-opaque pneumococcal variants had no statistically significant difference in patient backgrounds. Although the pneumonia severity index score did not differ between the opaque and non-opaque groups, the rate of bacteremia was significantly higher in the opaque group than in the non-opaque group. Serotype distribution was similar between the groups. Conclusions. Opaque pneumococcal variants may cause pneumonia and invasive diseases in humans. This study could help elucidate IPD, and opacity assessment may serve as a predictor for IPD.


  • A case of bilateral emphysematous pyelonephritis caused by Candida albicans

    by Shuhei Ideguchi, Kazuko Yamamoto, Akihiko Ikeda, Kimio Hashimoto, Takahiro Takazono, Tomomi Saijo, Yoshifumi Imamura, Taiga Miyazaki, Hiroshi Mukae


  • Factors Associated with Diagnostic Yield of Endobronchial Ultrasonography with a Guide Sheath for Peripheral Lung Cancer

    by Keigo Uchimura, Kei Yamasaki, Hiroshi Ishimoto, Sho Kakinouchi, Koki Kimura, Tomoko Kanaya, Takafumi Matsunaga, Takako Kawaguchi, Yoko Fukuda, Kazuki Sakagami, et al.

    近年,末梢肺病変の診断率改善のためにガイドシース併用気管支腔内超音波断層法(endobronchial ultrasonography with a guide sheath(EBUS-GS))は汎用される手技となっている.本研究ではEBUS-GSを用いた末梢型肺癌の診断関連因子を後ろ向きに検討した.2014年8月から2015年9月に産業医科大学病院呼吸器内科でEBUSGSを行い,最終的に原発性肺癌と診断した症例(76例)を対象とした.末梢型肺癌の診断率は71.1%であった.診断に関連した因子として,病変の位置,大きさ,性状,bronchus signの有無,EBUSプローブの位置,EBUS所見検出の有無,生検回数,検査時間,仮想気管支鏡ナビゲーションの使用,超音波気管支鏡ガイド下針生検併用の有無,CTスライスの厚さ,術者の医師経験年数,国立がん研究センターでの気管支鏡修練(前後)について検討した.病変の大きさ ≧ 20 mm( 80.8% vs. 50.0%, P = 0.006),EBUSプローブの位置 “within”(90.0% vs. 50.0%, P < 0.001),EBUS所見検出あり(80.7% vs. 28.6%, P < 0.001),生検回数 ≧ 5回(78.0% vs. 47.1%, P = 0.013),気管支鏡修練後(81.6% vs. 60.5%, P = 0.043)において有意に診断率が高かった.多変量解析では,EBUSプローブの位置 “within”( オッズ比14.10, 95%信頼区間3.53 - 56.60, P < 0.001),気管支鏡修練(オッズ比6.93, 95%信頼区間1.86 - 25.80, P = 0.004)の順に診断に寄与していた.EBUS-GSを用いた末梢型肺癌の診断率向上には,EBUSプローブの位置が病変に入っている状態(within)であること,気管支鏡修練度の向上が有用と考えられた.